Systemic bevacizumab as adjuvant therapy for recurrent respiratory papillomatosis in children: A series of three pediatric cases and literature review

xlomafota13 shared this article with you from Inoreader Systemic bevacizumab as adjuvant therapy for recurrent respiratory papillomatosis in children: A series of three pediatric cases and literature review Via American Journal of Otolaryngology Publication date: September–October 2021 Source: American Journal of Otolaryngology, Volume 42, Issue 5 Author(s): Ortiz H. Enrique, Sanchez H. Eloy, Trujillo P. Adrian, Villamor Perla View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.